AstraZeneca's Guide to Advancing 'East-West Integrated Innovation': Insights from the 7th China Ecosystem Conference

As the most "localized" presence among multinational pharmaceutical companies, AstraZeneca is demonstrating its courage and strength by fostering a "diversified international health innovation ecosystem" to better support the early achievement of the grand goal of "Healthy China 2030."

AstraZeneca has been in China for over 30 years. Standing at the beginning of a new 30-year journey,AstraZeneca is expanding the well-known "China Health Innovation Ecosystem" among its ecosystem partners into a "Diversified International Health Innovation Ecosystem." The essence of this initiative has evolved from "Embracing Chinese Innovation" to "Innovation that Integrates Chinese and Western Expertise," aiming to create a dual circulation development model for both Chinese and international operations, thereby promoting global access to China's health innovation achievements.。

Plan first, then act. AstraZeneca will actively play the role of a bridge as a multinational enterprise, continuously driving the "China Health Innovation Ecosystem" constructed by the China Smart Health Innovation Center, the International Life Science Innovation Park, and the AstraZeneca CJ Healthcare Industry Fund. In addition, it will focus on key themes such as "innovation empowerment" and "international development," fostering new quality productivity characterized by "high quality, high efficiency, and high technology." While supporting "Healthy China 2030," it will also contribute to the global life sciences and healthcare industry.

So, what kind of "circle" is AstraZeneca's "Diversified International Health Innovation Ecosystem"? And how will it impact innovation in China and the global market?May 10th-11th, "The 7th AstraZeneca China Ecosystem Conference" held in Wuxi, Jiangsu, will provide answers.

In fact, AstraZeneca China Ecosystem Conference has become a key IP of AstraZeneca. It is an important gathering place for domestic and international healthcare partners to explore industry trends, seek potential business opportunities, and connect with global resources. For cross-industry partners, this is also an event that is both "High Quality, High Efficiency, High TechnologyIndustry Event Characterized by New Quality Productivity:

First, the specifications are high.AstraZeneca has participated in the "Taihu Bay Future Life Health Conference" for four consecutive years as a key strategic partner, while simultaneously hosting significant events. In 2024, AstraZeneca will also hold an event themed “Innovative Quality, Integrated Ecosystem"The 7th AstraZeneca China Ecosystem Conference" with the theme of

Secondly, the lineup of guests is strong.The conference covers guests from the six major circles of government, industry, academia, research, medicine, and investment, discussing hot topics such as ecosystem construction and international cooperation, which will attract...Nearly a thousand top experts, heavyweight guests, high-growth companies, technical experts, and professional investors from the life and health sector at home and abroadPartners from other industries are also invited to attend.

Next is the international perspective.The conference is dedicated to creating a global cooperation platform by setting up an international cooperation forum, promoting the "introduction and going-out" of innovative enterprises, innovative models, and innovative achievements; meanwhile, AstraZeneca will also share the latest progress and results of international expansion at the main summit of the conference.

Finally, cutting-edge and diverse topics.In the field of life and healthLatest Policy Trends, Chronic Disease Management, Early Cancer Screening, Precision Medicine, China's Innovation Going Global, Patient Empowermentand other cutting-edge topics, focusing on treatment areas such as metabolism, respiratory, oncology, and rare diseases, hosting multiple forward-looking, high-quality, and professionally authoritative dialogues.

The conference adopted a "1+8+1" structure, namely1 Main Summit + 8 Thematic Sub-Forums + 1 Ecosystem Dinner, sharing the latest medical technologies, industry trends, and innovative models to maximize the perception of industry trends among attendees, explore cooperation and exchange, and connect global resources.

It is worth mentioning that AstraZeneca alsoA special off-site interactive area was set up., while showcasing excellent innovation cooperation cases and innovative achievements, a government investment promotion zone and a cooperation negotiation area are set up to facilitate close communication with potential partners and improve the efficiency of resource connection.

In addition, the conference also achievedGlobal Linkage, overseas guests from the international health innovation ecosystem will also come to the conference site to interact with local innovative enterprises and explore cooperation opportunities.

"As an important driving force for AstraZeneca to 'expand' the international health innovation ecosystem, the essence, extension, and core value of 'scientific research and innovation' will also be explained at the conference. Meanwhile,AstraZeneca will also announce the implementation of its full disease management model across multiple vertical disease areas.

AstraZeneca hopes to leverage its global advantages and deep insights into the Chinese local market to continuously gather global intellectual resources. At the same time, it actively serves as an international bridge to empower Chinese innovative enterprises, innovative models, and share innovation achievements with the world. Over the past six years, AstraZeneca has accumulated excellent experiences and achieved significant results in model innovation, digital transformation, and innovative cooperation with cross-border partners. This conference will also announce more innovative progress, which is worth looking forward to.

AstraZeneca is on the expansion track of a "Diversified International Health Innovation Ecosystem" and sincerely invites partners from all sectors to actively join the great cause of global healthcare innovation and shared development. Everyone is welcome!Scan the QR code below to follow the 【International Life Science Innovation Park】WeChat Official Account and register for the event.Participate in the 7th AstraZeneca China Ecosystem Conference, May 10th-11th, Wuxi, Jiangsu. See you there!

Event Time:May 10th - 11th

Venue:Wuxi International Conference Center (No. 100, Qingshu Road, Taihu New City, Binhu District, Wuxi City)

For use only at the "7th AstraZeneca China Ecosystem Conference".

Approval Number: CN-134228